| Name | Atorvastatin Acetonide |
|---|---|
| Synonyms |
2-[(4R,6R)-6-[2-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid
Atorvastatin Impurity 8 |
| Description | Atorvastatin acetonide is an impurity of Atorvastatin, and extracted from patent WO2011131605A1, Compound 4. Atorvastatin is an orally active HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. De Ben Lange, et al. PRODUCTION OF ATORVASTATIN LOW IN ETHER IMPURITIES. WO2011131605A1. |
| Molecular Formula | C36H39FN2O5 |
|---|---|
| Molecular Weight | 598.70400 |
| Exact Mass | 598.28400 |
| PSA | 93.28000 |
| LogP | 8.49590 |
|
~97%
581772-29-4 |
| Literature: NICOX S.A.; STORONI, Laura; BONFANTI, Annalisa; BENEDINI, Francesca; OLIVA, Francesca; MIGLIETTA, Daniela; ONGINI, Ennio Patent: WO2011/160974 A2, 2011 ; Location in patent: Page/Page column 28 ; |
|
~%
581772-29-4 |
| Literature: PIRAMAL LIFE SCIENCES LIMITED Patent: US2011/263526 A1, 2011 ; Location in patent: Page/Page column 80 ; |
|
~%
581772-29-4 |
| Literature: NICOX S.A.; STORONI, Laura; BONFANTI, Annalisa; BENEDINI, Francesca; OLIVA, Francesca; MIGLIETTA, Daniela; ONGINI, Ennio Patent: WO2011/160974 A2, 2011 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |